l carnitine and liver Frontiers Antioxidant, antiapoptotic, antigenotoxic, and hepatic

Epidermal barrier dysfunction in atopic dermatitis

Our carefully selected peptide therapies including NAD+, BPC-157, GHK-Cu, and Cagrilintide are designed to enhance cellular function, accelerate healing, improve recovery, and optimize overall performance

Research demonstrates GHK-Cu's ability to prevent toxic amyloid-beta formation associated with Alzheimer's disease while reducing cancer-promoting inflammatory pathways

Low NAD+ can impact nearly every part of your appearance and health

In some embodiments, the formulations or compositions described herein have a pH between about 5 and about 8, or between about 6 and about 7, or between about 6.5 and about 7, or between about 5.5 and about 7.5, or between about 7.1 and about 7.7, and have a concentration of active pharmaceutical ingredient between about 50 and about 80 mM

Use of L-selenomethionine can be the solution to mitigate the risk for lower selenium availability in the animal, especially when selenium (bio)availability from the diet is low due to variation in the raw materials and/or influenced by the production process